Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


STONEPINE CAPITAL, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/23/2023 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
03/02/2022 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/07/2021 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
08/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/22/2020 SC 13G STONEPINE CAPITAL, L.P. reports a 6.2% stake in Amryt Pharma plc
01/10/2020 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/12/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 5,202 shares @ $0.6916, valued at $3.6k
Bought 40 shares @ $0.69, valued at $27.6
Bought 1,000 shares @ $0.7, valued at $700
12/09/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 5,160 shares @ $0.7, valued at $3.6k
Bought 40 shares @ $0.7, valued at $28
Bought 4,500 shares @ $0.7, valued at $3.2k
11/26/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 89,845 shares @ $0.7461, valued at $67k
10/16/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 100,000 shares @ $0.649, valued at $64.9k
10/02/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
08/14/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Disposed of 1,000,000 shares @ $0
Acquired 1 warrants @ $0
Bought options to buy @ $3.25, valued at $0
03/20/2019 SC 13D/A STONEPINE CAPITAL, L.P. reports a 7.3% stake in Viveve Medical, Inc.
02/14/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
01/14/2019 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/31/2018 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Sold 250,000 shares @ $3, valued at $750k
12/28/2018 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Sold 500,000 shares @ $3, valued at $1.5M
11/21/2018 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Bought 54,200 shares @ $3.4, valued at $184.3k
Bought 3,230 shares @ $3.605, valued at $11.6k
11/06/2018 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Bought 300,000 shares @ $5, valued at $1.5M
01/08/2018 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2017 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Bought 5,287 shares @ $5, valued at $26.4k
12/22/2017 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.
Txns: Bought 45,434 shares @ $4.4969, valued at $204.3k
Bought 98,324 shares @ $4.9423, valued at $485.9k
Bought 41,399 shares @ $4.9968, valued at $206.9k
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
03/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/09/2017 D/A Form D/A - Notice of Exempt Offering of Securities [Amend]
12/01/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/21/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/17/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
11/02/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
09/29/2016 D/A Form D/A - Notice of Exempt Offering of Securities [Amend]
09/23/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
09/16/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy